Category Archives : News


JAMA-OTO study by researchers at HealthCore and UT Southwestern Medical Center finds surgery, radiation therapy equally effective in treating common type of head and neck cancer

– For both cohorts survival rates at 3 years exceed 75%, an improvement from prior decades DALLAS – Sept. 20,   Read More

HealthCore Announces First-Time Direct Access to its Research Data for Improved Insights and Decision Making

WILMINGTON, Del.—May 21, 2018—Life sciences companies can – for the first time – access one of the largest commercially insured   Read More

HealthCore and Blue Cross Blue Shield Association Study Shows Low Uptake of HPV Vaccine Compared to Other Adolescent Immunizations

– Fewer than a third of adolescents received a first dose of HPV vaccine by their 13th birthday – Wide   Read More

Blue Cross Blue Shield Association Study Shows Significant Increase in Children Who Receive All Recommended Vaccines

Proportion of children receiving all CDC recommended vaccines increases 12 percent over seven years – Variations exist in vaccine rates   Read More

Anthem Health Plans Play Major Role in Trial to Determine Best Aspirin Dose to Prevent Heart Attacks and Strokes

Trial funded by Patient-Centered Outcomes Research Institute aims to compare the benefits and risks for two commonly used doses of   Read More

Anthem, HealthCore and Wharton launch collaboration to study and pilot new health care ideas

Research will focus on improving health care quality, affordability and accessibility INDIANAPOLIS/PHILADELPHIA—Oct. 23, 2017—Anthem, Inc. and the Wharton School of   Read More

Ambitions of the World’s Largest Pragmatic Clinical Trial in COPD

Pragmatic clinical trials (PCTs) promise to address much of healthcare’s urgent need for real-world evidence to inform and improve decision-making   Read More

Anthem, HealthCore and Boehringer Ingelheim Initiate World’s Largest Pragmatic Clinical Trial to Study People Living with COPD in a Real-World Setting

 The world’s largest randomized pragmatic trial to study the impact of treatments on COPD exacerbations Study will compare time to   Read More

HealthCore acquisition of NERI strengthens pre-approval and special populations research

WILMINGTON, Del. & WATERTOWN, Mass. —September 12, 2017—HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc., today announced that it   Read More

Certain Patients with Type 2 Diabetes Less Likely to Suffer Heart Failure While Taking New Class of Antidiabetic Drug

HealthCore study is the first to report a direct comparison of two new medication classes on risk of heart failure   Read More